• Facebook
  • Twitter
  • LinkedIn
  • Google +
  • RSS

Pharma news

The latest news from the pharmaceutical industry and suppliers. If you have a piece of news that you would like us to cover, please contact Victoria White on +44 (0)1959 563311 or email us.

Industry News

Executive leadership team named for the combined Allergan Pfizer business

Posted on: 8 February 2016

The close of the transaction to combine Pfizer and Allergan is expected in the second half of 2016, and is subject to certain conditions...

RedHill Biopharma and IZI enter RP101 collaboration

Posted on: 8 February 2016

The research collaboration will test RP101 in preclinical oncology models in combination with standard-of-care chemotherapies to support existing Phase I and Phase II clinical data...

New toolkit informs of the risks of taking valproate during pregnancy

Posted on: 8 February 2016

Valproate is associated with a risk of birth defects and developmental disorders in children born to women who take the treatment during pregnancy...

NICE says ‘no’ to alirocumab in draft guidance

Posted on: 8 February 2016

NICE was concerned that alirocumab had not been compared with the combination therapy of ezetimibe plus a statin and that trials of the drug were not able to provide robust information on cardiovascular outcomes...

FDA approves expanded use of Daklinza in HCV genotypes 1 and 3

Posted on: 8 February 2016

The expanded label for Daklinza includes three additional patient populations: HCV patients with HIV-1 coinfection, advanced cirrhosis, or post-liver transplant recurrence of HCV...

ImmunoGen and Merck collaborate for ovarian cancer trial

Posted on: 5 February 2016

The companies are to are to assess ImmunoGen’s mirvetuximab soravtansine in combination with Merck’s Keytruda (pembrolizumab) in FRα-positive ovarian cancer...

Public Accounts Committee publishes report on the Cancer Drugs Fund

Posted on: 5 February 2016

A Public Accounts Committee has released its recommendations for the reform of the Cancer Drugs Fund...

Aridhia’s Dr David Sibbald honoured with Outstanding Contribution Award

Posted on: 5 February 2016

Dr David Sibbald OBE, co-founder and Chairman of Aridhia, was awarded the ‘Outstanding Contribution Award’ at the Scottish Enterprise Life Sciences Awards...

Muzammil Mansuri is Sanofi’s new Executive Committee member

Posted on: 5 February 2016

Mr. Mansuri joins Sanofi from Gilead Sciences and will take the position of Executive Vice President, Strategy & Business Development...

Positive topline results from GAUSS-3 trial of Repatha

Posted on: 5 February 2016

The Phase 3 GAUSS-3 trial evaluating Amgen’s Repatha (evolocumab) in patients with high cholesterol who cannot tolerate statins met its co-primary endpoints...

NovaBiotics wins Life Science Investment of the Year Award

Posted on: 5 February 2016

NovaBiotics was awarded the Life Science Investment of the Year Award at the Scottish Enterprise Life Sciences Annual Awards...

Phase 3 study of Blincyto in ALL meets primary endpoint

Posted on: 5 February 2016

Blincyto is a BiTE antibody construct that binds specifically to CD19 expressed on the surface of cells of B-lineage origin and CD3 expressed on the surface of T cells...

 

Supplier News

BIO-Europe Spring® 2016 Event in Sweden this April will bring 2,000+ life science executives to Stockholm-Uppsala region

Posted on: 8 February 2016

The tenth annual BIO-Europe Spring® springtime international life science partnering conference will be held in Stockholm, Sweden, April 4–6, 2016...

Honeywell completes acquisition of research chemicals business from Sigma-Aldrich

Posted on: 5 February 2016

The acquisition broadens Honeywell’s research chemicals portfolio and expands the company's global reach...

Continuous processing will require a change in mindset for controls and automation

Posted on: 4 February 2016

Continuous processing for secondary manufacturing in pharma is still one of the hottest topics currently discussed...

CHIRAL ART polysaccharide HPLC columns by YMC now with 3 µm!

Posted on: 3 February 2016

To overcome the need of method developers for faster and high-resolution methods, YMC now offers all of its CHIRAL ART polysaccharide HPLC columns with a particle size of 3 µm...

New microbial testing technology for cleanrooms announced by MOCON, Particle Measuring Systems

Posted on: 3 February 2016

Cleanroom operators will now be able to detect the presence of extremely low levels of microbial cells on surfaces much faster than traditional solutions...

Tecan simplifies large molecule bioanalysis

Posted on: 2 February 2016

Tecan has launched a fully automated affinity purification solution for the extraction of large biomolecules, such as proteins, antibodies and antibody-drug conjugates...

Easily measure cancer cell death in a co-culture with KILR™ Assays from DiscoverX

Posted on: 2 February 2016

DiscoverX Corporation announced the launch of the KILR Cytotoxicity Assay, a pioneering approach to accelerate the development of cancer immunotherapy drugs...

Sartorius grows by double digits in sales and profit in 2015 – positive outlook for 2016 – targets for 2020 updated

Posted on: 1 February 2016

Sartorius grew very dynamically again in 2015 according to its preliminary figures and further increased its profitability...

Presentation videos from the World’s 1st International Pharmaceutical seminar on Transmission Raman Spectroscopy available online

Posted on: 27 January 2016

Videos of the presentations from the world’s 1st TRS seminar for quantitative pharmaceutical analysis can be viewed on demand...

Empower your research with Tecan’s Spark® 20M multimode reader

Posted on: 25 January 2016

Tecan has launched the Spark® 20M multimode microplate reader, offering tailor-made solutions to suit virtually any drug discovery or advanced life science research application...

Sartorius Stedim Biotech presents new crossflow filtration system for process development

Posted on: 21 January 2016

The ideal solution for scaling studies and low volume ultra- and diafiltration operations...

Shire bets big on rare diseases

Posted on: 20 January 2016

Speciality pharma firm Shire has agreed to buy Baxalta for around $32 billion (£22 billion), to further expand its portfolio of treatments for rare diseases...

 

 

Webinar: The 9 validation steps required for thermal analysis method validation in an analytical laboratoryWATCH NOW
+ +